NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market Monday that its fourth-quarter revenues rose 3 percent on a non-GAAP basis but were down 1 percent on a GAAP basis.

The Carlsbad, Calif.-based genetic analysis tools firm reported total revenues of $998.9 million for the three months ended Dec. 31, compared to $1.01 billion for the fourth quarter of 2011. However, on a non-GAAP basis, its revenues were up 3 percent to $999.4 million from $970.3 million. Excluding the effects of currency translation its revenues were up 4.5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.